Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.

Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M.

Tob Control. 2010 Apr;19(2):98-103. doi: 10.1136/tc.2009.031567.

PMID:
20378585
2.

Evaluating oral noncombustible potential-reduced exposure products for smokers.

Blank MD, Eissenberg T.

Nicotine Tob Res. 2010 Apr;12(4):336-43. doi: 10.1093/ntr/ntq003. Epub 2010 Feb 16.

3.

Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration.

Eissenberg T.

Tob Control. 2010 Feb;19(1):87-8. doi: 10.1136/tc.2009.033498. No abstract available.

4.

Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

O'Connor RJ, Cummings KM, Rees VW, Connolly GN, Norton KJ, Sweanor D, Parascandola M, Hatsukami DK, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3334-48. doi: 10.1158/1055-9965.EPI-09-0429. Review.

5.

Abuse liability assessment of tobacco products including potential reduced exposure products.

Carter LP, Stitzer ML, Henningfield JE, O'Connor RJ, Cummings KM, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3241-62. doi: 10.1158/1055-9965.EPI-09-0948. Review.

6.

Measures for assessing subjective effects of potential reduced-exposure products.

Hanson K, O'Connor R, Hatsukami D.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3209-24. doi: 10.1158/1055-9965.EPI-09-0971. Review.

7.

Waterpipe tobacco and cigarette smoking: direct comparison of toxicant exposure.

Eissenberg T, Shihadeh A.

Am J Prev Med. 2009 Dec;37(6):518-23. doi: 10.1016/j.amepre.2009.07.014.

8.

Test marketing of new smokeless tobacco products in four U.S. cities.

Rogers JD, Biener L, Clark PI.

Nicotine Tob Res. 2010 Jan;12(1):69-72. doi: 10.1093/ntr/ntp166. Epub 2009 Nov 16.

9.

Electronic cigarettes: safety concerns and regulatory issues.

Wollscheid KA, Kremzner ME.

Am J Health Syst Pharm. 2009 Oct 1;66(19):1740-2. doi: 10.2146/ajhp090127. No abstract available. Erratum in: Am J Health Syst Pharm. 2009 Nov 1;66(21):1900.

PMID:
19767381
10.

Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers.

Cobb CO, Weaver MF, Eissenberg T.

Tob Control. 2010 Oct;19(5):367-73. doi: 10.1136/tc.2008.028993. Epub 2009 Apr 2.

11.

Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.

Gray JN, Breland AB, Weaver M, Eissenberg T.

Nicotine Tob Res. 2008 Sep;10(9):1441-8. doi: 10.1080/14622200802323258.

12.

The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.

Kleykamp BA, Jennings JM, Sams C, Weaver MF, Eissenberg T.

Exp Clin Psychopharmacol. 2008 Apr;16(2):99-112. doi: 10.1037/1064-1297.16.2.99.

PMID:
18489014
13.

Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers.

Blank MD, Sams C, Weaver MF, Eissenberg T.

Nicotine Tob Res. 2008 Mar;10(3):417-21. doi: 10.1080/14622200801901880.

15.

Clinical laboratory evaluation of potential reduced exposure products for smokers.

Breland AB, Kleykamp BA, Eissenberg T.

Nicotine Tob Res. 2006 Dec;8(6):727-38.

PMID:
17132520
16.

Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Evans SE, Blank M, Sams C, Weaver MF, Eissenberg T.

Exp Clin Psychopharmacol. 2006 May;14(2):121-35.

17.

New tobacco products: do smokers like them?

Caraballo RS, Pederson LL, Gupta N.

Tob Control. 2006 Feb;15(1):39-44.

18.

The time for tobacco industry sponsored PREP evaluation has arrived.

Eissenberg T.

Tob Control. 2006 Feb;15(1):1-2. No abstract available.

19.

Smoker awareness of and beliefs about supposedly less-harmful tobacco products.

O'Connor RJ, Hyland A, Giovino GA, Fong GT, Cummings KM.

Am J Prev Med. 2005 Aug;29(2):85-90.

PMID:
16005803
20.

The effect of a novel smoking system--Accord--on ongoing smoking and toxin exposure.

Hughes JR, Keely JP.

Nicotine Tob Res. 2004 Dec;6(6):1021-7.

PMID:
15801575

Supplemental Content

Support Center